brokers note13 Jul 2020 13:15
https://cutt.ly/tpP7JE3
The three companies, which are all TPI clients, are collaborating to deliver a
unique package of wastewater SARS-CoV-2 hotspot detection and followthrough individual COVID-19 test-kits. Multiple international commercial
opportunities exist beyond individual equipment unit sales, with all three
parties standing to enjoy long-term recurring revenues generated through the
supply of Affimer®
reagents in each of the proprietary consumable test
cartridges, AI-as-a-Service predictive alerts and maintenance contracts. The
true scale of this opportunity is perfectly demonstrated by, for example, the
global cruise line industry which handles 32 million passengers in a market
annually worth US$31.5 billion, yet is likely to remain entirely disabled and
passengers effectively uninsurable until perpetual coronavirus monitoring,
detection and testing systems are installed. In this respect, Avacta, Integumen
and Modern Water appear to have not only rapidly recognised one of the
world’s most pressing needs, but are also combining their core competencies
and well-established worldwide marketing reach to develop and distribute a
unique, seemingly unmatched technological package of potential global
significance.